Samjin Pharmaceuticals Co., Ltd.

KOSE:A005500 Stock Report

Market Cap: ₩222.5b

Samjin Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Yong-Joo Choi

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.5yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Estimating The Intrinsic Value Of Samjin Pharmaceuticals Co., Ltd. (KRX:005500)

Nov 21
Estimating The Intrinsic Value Of Samjin Pharmaceuticals Co., Ltd. (KRX:005500)

CEO

Yong-Joo Choi (57 yo)

2.5yrs

Tenure

Yong-Joo Choi serves as a Director at Samjin Pharmaceutical Co. Ltd. since March 25, 2022 and serves as its Chairman of the Board since 2023. Yong-Joo Choi is Chief Executive Officer at Samjin Pharmaceutic...


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:40
End of Day Share Price 2024/12/20 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Samjin Pharmaceuticals Co., Ltd. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyung Soo KimCape Investment & Securities Co., Ltd.
Hyuk Jin YoonEugene Investment & Securities Co Ltd.
Jae Hoon ShinHanwha Investment & Securities Co., Ltd.